Luc Van Kaer Selected Research

Luc Van Kaer Research Topics

Disease

21	Inflammation (Inflammations) 01/2022 - 04/2003
12	Tuberculosis (Tuberculoses) 01/2020 - 11/2011
12	Infections 11/2019 - 04/2002
10	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 04/2002
8	Neoplasms (Cancer) 01/2017 - 03/2002
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2002
6	Leukemia 01/2017 - 11/2008
6	Atherosclerosis 04/2013 - 06/2004
5	Multiple Sclerosis 01/2022 - 06/2004
5	Obesity 01/2022 - 05/2012
4	Disease Progression 01/2021 - 06/2004
4	Colitis 01/2017 - 01/2011
4	Insulin Resistance 01/2016 - 05/2012
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2011 - 06/2004
3	Sepsis (Septicemia) 03/2021 - 01/2015
3	Reinfection 01/2017 - 06/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2011 - 06/2004
3	Myasthenia Gravis 06/2010 - 12/2005
2	Malaria 01/2019 - 03/2002
2	Communicable Diseases (Infectious Diseases) 01/2017 - 11/2016
2	Uveitis 12/2016 - 08/2003
2	Pulmonary Tuberculosis 11/2016 - 01/2009
2	Bacterial Infections (Bacterial Infection) 06/2015 - 09/2003
2	Virus Diseases (Viral Diseases) 02/2013 - 02/2011
2	Hepatitis 06/2008 - 10/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2005 - 06/2004
2	Lupus Nephritis 04/2005 - 08/2003
2	Dermatitis 06/2004 - 10/2003
2	Granuloma 07/2002 - 01/2002
1	Lewis Lung Carcinoma 01/2021
1	Parasitemia 01/2019
1	Hyperlactatemia 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Sarcoidosis (Schaumann Disease) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Cadaver (Cadavers) 01/2017

Drug/Important Bio-Agent (IBA)

19	CytokinesIBA 01/2022 - 05/2002
18	alpha-galactosylceramideIBA 02/2009 - 03/2002
15	AntigensIBA 01/2017 - 03/2002
13	GlycolipidsIBA 01/2022 - 01/2002
7	Interleukin-10 (Interleukin 10)IBA 10/2019 - 01/2011
7	LigandsIBA 01/2018 - 05/2002
6	LipidsIBA 01/2020 - 12/2004
5	Interleukin-17 (Interleukin 17)IBA 11/2019 - 01/2011
5	Interleukin-4 (Interleukin 4)IBA 11/2019 - 04/2005
5	VaccinesIBA 11/2016 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2007
3	LipopolysaccharidesIBA 03/2021 - 11/2006
3	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 10/2014
3	Apolipoproteins E (ApoE)IBA 04/2013 - 10/2004
3	ApolipoproteinsIBA 04/2013 - 10/2004
3	Histocompatibility Antigens Class IIBA 10/2011 - 03/2005
3	Cholinergic ReceptorsIBA 06/2010 - 12/2005
3	Concanavalin AIBA 06/2008 - 10/2004
2	Class III Phosphatidylinositol 3-KinasesIBA 01/2022 - 01/2021
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 01/2021
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2013
2	CurcuminIBA 11/2019 - 01/2017
2	AntibodiesIBA 01/2017 - 10/2009
2	Peptides (Polypeptides)IBA 12/2016 - 04/2002
2	interstitial retinol-binding proteinIBA 12/2016 - 08/2003
2	Interleukin-12 (IL 12)IBA 06/2015 - 06/2008
2	Pharmaceutical PreparationsIBA 06/2014 - 01/2011
2	Messenger RNA (mRNA)IBA 02/2013 - 12/2012
2	Monoclonal AntibodiesIBA 04/2011 - 11/2006
2	Galactosylceramides (Galactocerebrosides)IBA 02/2011 - 01/2002
2	Neutralizing AntibodiesIBA 01/2011 - 10/2004
2	AutoantigensIBA 01/2011 - 12/2005
2	Immunoglobulin G (IgG)IBA 01/2011 - 01/2008
2	thymus-leukemia antigensIBA 11/2010 - 11/2008
2	EpitopesIBA 01/2008 - 10/2004
2	HydrocarbonsIBA 04/2005 - 08/2003
2	pristane (pristan)IBA 04/2005 - 08/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	GalactosamineIBA 03/2021
1	ChromatinIBA 03/2021
1	SilverIBA 01/2021
1	perchlorateIBA 01/2021
1	EstersIBA 01/2021
1	tetramethylrhodamine (T 489)IBA 01/2021
1	Propidium (Propidium Iodide)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	SAR405IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 11/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	graphene oxideIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	bergeninIBA 01/2017
1	Granzymes (Granzyme)IBA 01/2017
1	GoldIBA 01/2017
1	MucinsIBA 01/2017
1	Antitubercular AntibioticsIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Freund's AdjuvantIBA 12/2016

Therapy/Procedure

10	Therapeutics 01/2018 - 01/2005
8	Immunotherapy 01/2022 - 06/2004